VIRGINIA RETIREMENT SYSTEMS ET Al Purchases Shares of 79,023 Elanco Animal Health Incorporated $ELAN

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Elanco Animal Health Incorporated (NYSE:ELAN) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 79,023 shares of the company’s stock, valued at approximately $1,128,000.

Other large investors also recently bought and sold shares of the company. Allworth Financial LP lifted its holdings in Elanco Animal Health by 791.7% in the first quarter. Allworth Financial LP now owns 2,354 shares of the company’s stock valued at $25,000 after acquiring an additional 2,090 shares during the period. Wealthquest Corp acquired a new position in Elanco Animal Health in the first quarter valued at approximately $56,000. Parallel Advisors LLC lifted its holdings in Elanco Animal Health by 66.6% in the second quarter. Parallel Advisors LLC now owns 6,432 shares of the company’s stock valued at $92,000 after acquiring an additional 2,572 shares during the period. Covestor Ltd raised its stake in shares of Elanco Animal Health by 510.9% during the 1st quarter. Covestor Ltd now owns 7,087 shares of the company’s stock worth $74,000 after buying an additional 5,927 shares during the period. Finally, GAMMA Investing LLC raised its stake in shares of Elanco Animal Health by 540.4% during the 2nd quarter. GAMMA Investing LLC now owns 7,557 shares of the company’s stock worth $108,000 after buying an additional 6,377 shares during the period. 97.48% of the stock is owned by institutional investors and hedge funds.

Elanco Animal Health Stock Up 0.6%

Shares of ELAN opened at $21.77 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.40 and a current ratio of 2.60. Elanco Animal Health Incorporated has a one year low of $8.02 and a one year high of $21.82. The stock has a market capitalization of $10.82 billion, a price-to-earnings ratio of 25.31, a PEG ratio of 3.97 and a beta of 1.65. The stock has a 50 day moving average price of $19.23 and a 200 day moving average price of $15.08.

Elanco Animal Health (NYSE:ELAN) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.20 by $0.06. Elanco Animal Health had a return on equity of 7.04% and a net margin of 9.68%.The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.19 billion. During the same period in the previous year, the business earned $0.30 earnings per share. The firm’s revenue for the quarter was up 4.8% on a year-over-year basis. Elanco Animal Health has set its Q3 2025 guidance at 0.120-0.160 EPS. FY 2025 guidance at 0.850-0.91 EPS. Equities research analysts forecast that Elanco Animal Health Incorporated will post 0.91 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ELAN has been the subject of several research analyst reports. Wall Street Zen raised Elanco Animal Health from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. UBS Group upped their target price on Elanco Animal Health from $19.00 to $25.00 and gave the stock a “buy” rating in a research note on Monday. Leerink Partnrs raised Elanco Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 17th. Zacks Research raised Elanco Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 3rd. Finally, Leerink Partners raised Elanco Animal Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research note on Thursday, July 17th. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.00.

Elanco Animal Health Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.